Format

Send to

Choose Destination
Nat Med. 2000 Jan;6(1):41-8.

Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1.

Author information

1
Department of Microbiology, Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois, 60611, USA.

Abstract

Thrombospondin-1 (TSP-1) is a naturally occurring inhibitor of angiogenesis that limits vessel density in normal tissues and curtails tumor growth. Here, we show that the inhibition of angiogenesis in vitro and in vivo and the induction of apoptosis by thrombospondin-1 all required the sequential activation of CD36, p59fyn, caspase-3 like proteases and p38 mitogen-activated protein kinases. We also detected increased endothelial cell apoptosis in situ at the margins of tumors in mice treated with thrombospondin-1. These results indicate that thrombospondin-1, and possibly other broad-spectrum natural inhibitors of angiogenesis, act in vivo by inducing receptor-mediated apoptosis in activated microvascular endothelial cells.

PMID:
10613822
DOI:
10.1038/71517
[Indexed for MEDLINE]

Publication types, MeSH terms, Substances, Grant support

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center